A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)
NCT01401985 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 95
Last updated 2026-05-22
Summary
A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation
Conditions
- Opioid Induced Constipation
Interventions
- DRUG
-
TD-1211
Capsules
- DRUG
-
Capsules
Sponsors & Collaborators
-
Theravance Biopharma
collaborator INDUSTRY -
Glycyx Therapeutics
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Theravance Biopharma
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-08-31
Countries
- United States
Study Locations
More Related Trials
-
A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).
NCT01957046 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.
NCT00414024 ·Status: TERMINATED ·Phase: PHASE3
-
Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit
NCT01050595 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
NCT00365820 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain
NCT00366431 ·Status: COMPLETED ·Phase: PHASE2
-
BLI801 Laxative in Constipated Adults
NCT01301781 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain
NCT01275755 ·Status: COMPLETED ·Phase: PHASE2
-
A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients
NCT00401362 ·Status: COMPLETED ·Phase: PHASE3
-
Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.
NCT03638440 ·Status: COMPLETED
-
A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults
NCT00583154 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
NCT00306748 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation
NCT01993875 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation
NCT03120520 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Methylnaltrexone (MNTX) for the Relief of Constipation
NCT00402038 ·Status: COMPLETED ·Phase: PHASE3
-
ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)
NCT01100151 ·Status: COMPLETED ·Phase: PHASE2
-
Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation
NCT01117051 ·Status: TERMINATED ·Phase: PHASE3
-
A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
NCT01687985 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
NCT02819310 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With Naloxegol
NCT04173858 ·Status: COMPLETED
-
Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation
NCT00501241 ·Status: TERMINATED ·Phase: PHASE2
-
Constipation Fiber Trial
NCT02193997 ·Status: COMPLETED ·Phase: NA
-
Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications
NCT05133076 ·Status: COMPLETED ·Phase: PHASE2
-
Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients
NCT00153153 ·Status: COMPLETED ·Phase: PHASE4
-
A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation
NCT01938196 ·Status: COMPLETED ·Phase: PHASE2
-
Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients
NCT00799201 ·Status: TERMINATED ·Phase: PHASE4